Our finding nevertheless makes the disturbed chromatin remodelling at IFN-γ-regulated promoters following Toxoplasma infection a promising and feasible target for a supportive therapy of toxoplasmosis. The gene discussed is IFNG; the disease is toxoplasmosis.